✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Patient medications,except statins and antiplatelets, were not assessed, and this wasreported as a limitation (1).
📌 3 Key Takeaways
🎯
Objective & Hypothesis:We have read with great interest the article by Yao et al. (1)on the association between baseline CRP levels and the occurrence of periprocedural myocardial infarction.
📊
Key Findings & Data:It is reported thathigher baseline CRP levels are associated with increased periprocedural myocardial infarction incidence.
💡
Conclusion & Impact:Patient medications,except statins and antiplatelets, were not assessed, and this wasreported as a limitation (1).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
We have read with great interest the article by Yao et al. (1)on the association between baseline CRP levels and the occurrence of periprocedural myocardial infarction. It is reported thathigher baseline CRP levels are associated with increased periprocedural myocardial infarction incidence. Patient medications,except statins and antiplatelets, were not assessed, and this wasreported as a limitation (1).
🔖
Cite This Article
OKŞUL, M., ŞENER, Y. Z., HEKİMSOY, V. (2019). Factors associated with periprocedural myocardial infarction. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 4, 239–240. https://ajindex.com/articles/366796